Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.
Adolescent
Adult
Aged
Betacoronavirus
/ isolation & purification
COVID-19
Child
Contact Tracing
Coronavirus Infections
/ diagnosis
Family Characteristics
Female
Health Personnel
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Travel-Related Illness
United States
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
05
2020
accepted:
15
08
2020
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
17
9
2020
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. In response to the first cases identified in the United States, close contacts of confirmed COVID-19 cases were investigated to enable early identification and isolation of additional cases and to learn more about risk factors for transmission. Close contacts of nine early travel-related cases in the United States were identified and monitored daily for development of symptoms (active monitoring). Selected close contacts (including those with exposures categorized as higher risk) were targeted for collection of additional exposure information and respiratory samples. Respiratory samples were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction at the Centers for Disease Control and Prevention. Four hundred four close contacts were actively monitored in the jurisdictions that managed the travel-related cases. Three hundred thirty-eight of the 404 close contacts provided at least basic exposure information, of whom 159 close contacts had ≥1 set of respiratory samples collected and tested. Across all actively monitored close contacts, two additional symptomatic COVID-19 cases (i.e., secondary cases) were identified; both secondary cases were in spouses of travel-associated case patients. When considering only household members, all of whom had ≥1 respiratory sample tested for SARS-CoV-2, the secondary attack rate (i.e., the number of secondary cases as a proportion of total close contacts) was 13% (95% CI: 4-38%). The results from these contact tracing investigations suggest that household members, especially significant others, of COVID-19 cases are at highest risk of becoming infected. The importance of personal protective equipment for healthcare workers is also underlined. Isolation of persons with COVID-19, in combination with quarantine of exposed close contacts and practice of everyday preventive behaviors, is important to mitigate spread of COVID-19.
Identifiants
pubmed: 32877446
doi: 10.1371/journal.pone.0238342
pii: PONE-D-20-14951
pmc: PMC7467265
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0238342Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet. 2020 Mar 28;395(10229):1039-1046
pubmed: 32192580
Int J Hyg Environ Health. 2020 Jul;228:113555
pubmed: 32460229
Lancet. 2020 Mar 14;395(10227):e47
pubmed: 32113505
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-352
pubmed: 32214086
J Korean Med Sci. 2017 May;32(5):744-749
pubmed: 28378546
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Emerg Infect Dis. 2016 Aug;22(8):1395-402
pubmed: 27191038
Lancet. 2020 Apr 4;395(10230):1137-1144
pubmed: 32178768
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Osong Public Health Res Perspect. 2020 Apr;11(2):81-84
pubmed: 32257773
EBioMedicine. 2020 May;55:102763
pubmed: 32361250
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
J Hosp Infect. 2020 Jun;105(2):119-127
pubmed: 32259546
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
Euro Surveill. 2020 Feb;25(6):
pubmed: 32070465
Emerg Infect Dis. 2016 Apr;22(4):647-56
pubmed: 26981708
MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146
pubmed: 32027631
Osong Public Health Res Perspect. 2020 Feb;11(1):8-14
pubmed: 32149037
Euro Surveill. 2020 Mar;25(11):
pubmed: 32209163
Emerg Infect Dis. 2020 Aug;26(8):1671-1678
pubmed: 32470316
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
MMWR Morb Mortal Wkly Rep. 2020 Mar 06;69(9):245-246
pubmed: 32134909